Skip to main content
    P

    Phreesia Inc (PHR)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $12.55
    -0.27 (-2.11%)

    Market Cap: $795.75M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Phreesia Inc (PHR) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Phreesia (PHR) has a market cap of $795.75M. Its share count is up 3.84% from a year earlier.

    Total Valuation

    Market Cap$795.75M
    Latest price (Nov 17, 2026)$12.55

    Key Dates

    The next earnings report is set for Dec 2, 2026, after the close.

    Next Earnings DateDec 2, 2026, after the close
    Last Earnings DateSep 2, 2026
    Fiscal Year EndJanuary

    Share Statistics

    The share count rose 1.53% in the quarter ended Jul 31, 2026 and grew 3.73% a year over 2 years.

    Shares Outstanding61.88M
    Shares Change (YoY)+3.84%
    Shares Change (QoQ)+1.53%
    Share Count Growth (2Y CAGR)+3.73%

    Valuation Ratios

    Sales and book value multiples are 1.5x and 2.1x.

    P/E Ratio12.9x
    Forward P/E40.1x
    P/S Ratio1.5x
    Forward P/S1.5x
    P/B Ratio2.1x
    P/TBV Ratio6.2x
    P/FCF Ratio11.5x
    P/OCF Ratio8.7x
    PEG Ratio0.2

    Valuation history and multiples

    Price Statistics

    The stock is down 42.35% over 52 weeks and trades 10.96% above its 50-day average.

    Beta (1Y)0.17
    52-Week Change-42.35%
    1-Month Change+11.26%
    3-Month Change+4.93%
    6-Month Change+36.86%
    5-Year Change-82.36%
    Total Return (1Y)-42.35%
    Total Return (3Y CAGR)-7.21%
    Total Return (5Y CAGR)-28.77%
    Return vs SPY (1Y)-47.53%
    Max Drawdown (1Y)-60.91%
    Max Drawdown (3Y)-75.24%
    Sharpe Ratio (1Y)-0.72
    Correlation with SPY (1Y)0.04
    50-Day Average$11.31
    200-Day Average$10.78
    52-Week Range$7.77 to $21.24
    RSI (14 Days)55.1
    Average Volume (20 Days)628.47K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.76x current liabilities, and total debt is 0.18x shareholder equity.

    Current Ratio1.76x
    Quick Ratio1.76x
    Debt / Equity0.18x
    Debt / EBITDA1.26x
    Debt / FCF0.98x

    Returns and Efficiency

    Return on invested capital is 2.72% over the last 12 months, against a 5-year average of -31.87%.

    Return on Equity (ROE)2.81%
    Return on Assets (ROA)1.61%
    Return on Invested Capital (ROIC)2.72%
    Return on Capital Employed (ROCE)2.37%
    ROE (5Y Average)-33.07%
    ROA (5Y Average)-24.64%
    ROIC (5Y Average)-31.87%
    Asset Turnover0.96x
    Receivables Turnover5.67x

    Scores

    PHR has an Altman Z-Score of 1.02, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score1.02
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $507.79M over the last 12 months is up 12.93% from the 12 months before.

    Revenue$507.79M
    Revenue Growth (YoY)+12.93%
    Gross Profit$475.20M
    Operating Income$12.54M
    Pretax Income$2.76M
    Net Income$10.45M
    EBITDA$52.90M
    EBIT$11.92M
    Reported EPS (TTM)$0.97

    Trailing 12 months through Jul 31, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 57.47% of the $646.98M in total assets.

    Total Debt$66.45M
    Working Capital$109.67M
    Shareholder Equity$371.85M
    Book Value Per Share$6.01
    Tangible Book Value$125.86M
    Tangible Book Per Share$2.03
    Total Assets$646.98M
    Total Liabilities$275.13M

    Balance sheet as of Jul 31, 2026.

    Full balance sheet

    Cash Flow

    After $23.86M of capital spending, operating cash flow left $67.52M of free cash flow.

    Operating Cash Flow$91.38M
    Capital Expenditures$23.86M
    Free Cash Flow$67.52M
    FCF Per Share$1.09
    Depreciation and Amortization$40.98M

    Trailing 12 months through Jul 31, 2026.

    Full cash flow statement

    Margins

    The operating margin is 2.47%, against a 5-year average of -34.23%.

    Gross Margin93.58%
    Operating Margin2.47%
    Pretax Margin0.54%
    Net Margin2.06%
    EBITDA Margin10.42%
    EBIT Margin2.35%
    FCF Margin13.30%
    Gross Margin (5Y Average)75.04%
    Operating Margin (5Y Average)-34.23%
    Net Margin (5Y Average)-34.00%

    Growth

    Revenue grew 19.60% a year over 3 years.

    Revenue Growth (3Y CAGR)+19.60%
    Revenue Growth (5Y CAGR)+26.45%
    Book Value Per Share Growth (2Y CAGR)+9.07%
    Tangible Book Per Share Growth (2Y CAGR)-45.21%

    Revenue and profit by year

    Dividends and Yields

    PHR does not pay a dividend. Its free cash flow yield is 8.69%.

    Earnings Yield7.75%
    FCF Yield8.69%
    Buyback Yield-0.23%
    Shareholder Yield-0.23%

    Peer Position

    Against 6 similar companies, PHR has the lowest P/E.

    P/E Ratio12.9x vs 35.5x median
    P/S Ratio1.5x vs 2.6x median
    ROIC2.72% vs -6.95% median
    Revenue Growth (Trailing 4 Quarters, YoY)+12.93% vs +11.95% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.47% and EPS growth at 12.64% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.47%
    EPS Growth Forecast (2Y CAGR)+12.64%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About PHR

    What is PHR's market cap?

    Phreesia has a market cap of $795.75M.

    What is PHR's P/E ratio?

    Phreesia has a trailing P/E ratio of 12.9x and a forward P/E of 40.1x.

    How many shares of PHR are outstanding?

    Phreesia has 61.88M shares outstanding. The count is up 3.84% from a year earlier.

    Does PHR pay a dividend?

    No. Phreesia does not pay a dividend.